VERACYTE, INC. - VCYT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | — | S | D | 529.0 | 53.5504 | 28,328.16 | 15,097.0 | View | |
| Jun 22, 2026 | — | S | D | 3,200.0 | 52.7832 | 168,906.24 | 15,626.0 | View | |
| Jun 15, 2026 | — | A | A | 5,272.0 | 0.0 | 0.0 | 18,826.0 | View | |
| Jun 15, 2026 | — | A | A | 5,272.0 | 0.0 | 0.0 | 31,100.0 | View | |
| Jun 15, 2026 | — | A | A | 5,272.0 | 0.0 | 0.0 | 56,461.0 | View | |
| Jun 15, 2026 | — | A | A | 5,272.0 | 0.0 | 0.0 | 57,718.0 | View | |
| Jun 15, 2026 | — | A | A | 5,272.0 | 0.0 | 0.0 | 32,471.0 | View | |
| Jun 15, 2026 | — | A | A | 5,272.0 | 0.0 | 0.0 | 44,582.0 | View | |
| Jun 15, 2026 | — | A | A | 5,272.0 | 0.0 | 0.0 | 31,100.0 | View | |
| Jun 15, 2026 | — | A | A | 5,272.0 | 0.0 | 0.0 | 34,634.0 | View | |
| Jun 04, 2026 | EVP, General Counsel | S | D | 1,776.0 | 50.1168 | 89,007.44 | 137,240.0 | View | |
| Jun 04, 2026 | EVP, General Counsel | S | D | 1,400.0 | 49.3061 | 69,028.54 | 139,016.0 | View | |
| Jun 04, 2026 | EVP, General Counsel | F | D | 3,292.0 | 47.8 | 157,357.6 | 140,416.0 | View | |
| Jun 04, 2026 | VP, Chief Accounting Officer | F | D | 1,361.0 | 47.8 | 65,055.8 | 44,073.0 | View | |
| Jun 04, 2026 | Chief Financial Officer | S | D | 1,961.0 | 50.0913 | 98,229.04 | 173,280.0 | View | |
| Jun 04, 2026 | Chief Financial Officer | S | D | 1,600.0 | 49.2836 | 78,853.76 | 175,241.0 | View | |
| Jun 04, 2026 | Chief Financial Officer | F | D | 3,693.0 | 47.8 | 176,525.4 | 176,841.0 | View | |
| Jun 04, 2026 | Chief Scientific & Med Officer | F | D | 3,730.0 | 47.8 | 178,294.0 | 149,797.0 | View | |
| Jun 04, 2026 | Chief Executive Officer | M | D | 138,051.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 04, 2026 | Chief Executive Officer | S | D | 138,051.0 | 50.1234 | 6,919,585.49 | 440,494.0 | View | |
| Jun 04, 2026 | Chief Executive Officer | M | A | 138,051.0 | 36.6 | 5,052,666.6 | 578,545.0 | View | |
| Jun 04, 2026 | Chief Executive Officer | F | D | 9,012.0 | 47.8 | 430,773.6 | 440,494.0 | View | |
| Jun 04, 2026 | Global Chief Commercial Off | S | D | 13,975.0 | 50.0703 | 699,732.44 | 132,305.0 | View | |
| Jun 04, 2026 | Global Chief Commercial Off | F | D | 4,059.0 | 47.8 | 194,020.2 | 146,280.0 | View | |
| May 27, 2026 | VP, Chief Accounting Officer | M | D | 24,000.0 | 0.0 | 0.0 | 0.0 | View | |
| May 27, 2026 | VP, Chief Accounting Officer | S | D | 24,000.0 | 45.401 | 1,089,624.0 | 45,434.0 | View | |
| May 27, 2026 | VP, Chief Accounting Officer | M | A | 24,000.0 | 24.8 | 595,200.0 | 69,434.0 | View | |
| May 22, 2026 | — | S | D | 10,000.0 | 44.0129 | 440,129.0 | 52,446.0 | View | |
| May 08, 2026 | SVP, General Counsel | S | D | 5,102.0 | 40.0 | 204,080.0 | 143,708.0 | View | |
| May 08, 2026 | SVP, General Counsel | S | D | 5,102.0 | 38.05 | 194,131.1 | 148,810.0 | View | |
| Apr 14, 2026 | Chief Dev and Tech Officer | A | A | 44,221.0 | 0.0 | 0.0 | 44,221.0 | View | |
| Mar 10, 2026 | Chief Financial Officer | A | A | 13,157.0 | 0.0 | 0.0 | 180,534.0 | View | |
| Mar 10, 2026 | Chief Financial Officer | A | A | 36,181.0 | 0.0 | 0.0 | 167,377.0 | View | |
| Mar 10, 2026 | Chief Executive Officer | A | A | 92,099.0 | 0.0 | 0.0 | 449,653.0 | View | |
| Mar 10, 2026 | VP, Chief Accounting Officer | A | A | 10,525.0 | 0.0 | 0.0 | 45,434.0 | View | |
| Mar 10, 2026 | Chief Commercial Officer-CLIA | A | A | 6,578.0 | 0.0 | 0.0 | 150,339.0 | View | |
| Mar 10, 2026 | Chief Commercial Officer-CLIA | A | A | 36,181.0 | 0.0 | 0.0 | 143,761.0 | View | |
| Mar 10, 2026 | Chief Scientific & Med Officer | A | A | 6,578.0 | 0.0 | 0.0 | 153,527.0 | View | |
| Mar 10, 2026 | Chief Scientific & Med Officer | A | A | 29,603.0 | 0.0 | 0.0 | 146,949.0 | View | |
| Mar 10, 2026 | SVP, General Counsel | A | A | 26,314.0 | 0.0 | 0.0 | 153,912.0 | View | |
| Mar 10, 2026 | SVP, General Counsel | A | A | 32,892.0 | 0.0 | 0.0 | 127,598.0 | View | |
| Mar 06, 2026 | Chief Financial Officer | S | D | 13,941.0 | 36.3288 | 506,459.8 | 131,196.0 | View | |
| Mar 06, 2026 | Chief Financial Officer | S | D | 4,400.0 | 35.5476 | 156,409.44 | 145,137.0 | View | |
| Mar 06, 2026 | SVP, General Counsel | S | D | 1,664.0 | 36.3393 | 60,468.6 | 94,706.0 | View | |
| Mar 06, 2026 | SVP, General Counsel | S | D | 4,994.0 | 35.2936 | 176,256.24 | 96,370.0 | View | |
| Mar 06, 2026 | Chief Commercial Officer-CLIA | S | D | 5,260.0 | 35.1868 | 185,082.57 | 107,580.0 | View | |
| Mar 06, 2026 | Chief Executive Officer | S | D | 26,279.0 | 36.2787 | 953,367.96 | 357,554.0 | View | |
| Mar 06, 2026 | Chief Executive Officer | S | D | 19,244.0 | 35.5553 | 684,226.19 | 383,833.0 | View | |
| Mar 04, 2026 | Chief Scientific & Med Officer | S | D | 13,425.0 | 36.1586 | 485,429.21 | 117,346.0 | View | |
| Mar 04, 2026 | Chief Scientific & Med Officer | F | D | 6,035.0 | 36.01 | 217,320.35 | 130,771.0 | View | |
| Mar 04, 2026 | Chief Commercial Officer-CLIA | F | D | 7,517.0 | 36.01 | 270,687.17 | 112,840.0 | View | |
| Mar 04, 2026 | Chief Financial Officer | F | D | 7,234.0 | 36.01 | 260,496.34 | 149,537.0 | View | |
| Mar 04, 2026 | VP, Chief Accounting Officer | F | D | 3,006.0 | 36.01 | 108,246.06 | 34,909.0 | View | |
| Mar 04, 2026 | SVP, General Counsel | F | D | 6,902.0 | 36.01 | 248,541.02 | 101,364.0 | View | |
| Mar 04, 2026 | Chief Executive Officer | F | D | 19,455.0 | 36.01 | 700,574.55 | 403,077.0 | View | |
| Mar 02, 2026 | SVP, General Counsel | F | D | 10,867.0 | 38.75 | 421,096.25 | 108,266.0 | View | |
| Mar 02, 2026 | SVP, General Counsel | A | A | 50,999.0 | 0.0 | 0.0 | 119,133.0 | View | |
| Mar 02, 2026 | Chief Scientific & Med Officer | F | D | 24,486.0 | 38.75 | 948,832.5 | 136,806.0 | View | |
| Mar 02, 2026 | Chief Scientific & Med Officer | A | A | 71,806.0 | 0.0 | 0.0 | 161,292.0 | View | |
| Mar 02, 2026 | Chief Financial Officer | F | D | 12,049.0 | 38.75 | 466,898.75 | 156,771.0 | View | |
| Mar 02, 2026 | Chief Financial Officer | A | A | 59,324.0 | 0.0 | 0.0 | 168,820.0 | View | |
| Mar 02, 2026 | Chief Executive Officer | F | D | 35,841.0 | 38.75 | 1,388,838.75 | 422,532.0 | View | |
| Mar 02, 2026 | Chief Executive Officer | A | A | 139,074.0 | 0.0 | 0.0 | 458,373.0 | View | |
| Mar 02, 2026 | Chief Commercial Officer-CLIA | F | D | 8,905.0 | 38.75 | 345,068.75 | 120,357.0 | View | |
| Mar 02, 2026 | Chief Commercial Officer-CLIA | A | A | 47,149.0 | 0.0 | 0.0 | 129,262.0 | View |